16 pending office actions • 2 clients
| Client (Assignee) | Pending OAs |
|---|---|
| Incyte Corporation | 15 |
| Incyte Holdings Corporation | 1 |
| App # | Title | Client | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|---|
| 18602434 | Bicyclic Ureas As Kinase Inhibitors | Incyte Corporation | CHAO, ALLEN | 1622 | Non-Final OA | Mar 12, 2024 |
| 18584553 | Heterocyclic Compounds As Kinase Inhibitors | Incyte Corporation | CHAO, ALLEN | 1622 | Non-Final OA | Feb 22, 2024 |
| 18512625 | Heteroaryl Fluoroalkenes As DGK Inhibitors | Incyte Corporation | CHAO, ALLEN | 1622 | Non-Final OA | Nov 17, 2023 |
| 18512514 | Heteroaryl Fluoroalkenes As DGK Inhibitors | Incyte Corporation | CHAO, ALLEN | 1622 | Non-Final OA | Nov 17, 2023 |
| 18381943 | Tricyclic Urea Compounds As JAK2 V617F Inhibitors | Incyte Corporation | ISMAIL, REHANA | 1625 | Final Rejection | Oct 19, 2023 |
| 18373648 | ANTI-PD-1/LAG-3 BISPECIFIC ANTIBODIES AND USES THEREOF | Incyte Corporation | REDDIG, PETER J | 1646 | Non-Final OA | Sep 27, 2023 |
| 18232970 | TRICYCLIC TRIAZOLO COMPOUNDS AS DGK INHIBITORS | Incyte Corporation | REDWOOD, CHRISTOPHER EVAN | 1629 | Non-Final OA | Aug 11, 2023 |
| 18179838 | SOLID FORMS, SALTS, AND PROCESSES OF PREPARATION OF A CDK2 INHIBITOR | Incyte Corporation | TOWNSLEY, SARA ELIZABETH | 1629 | Non-Final OA | Mar 07, 2023 |
| 18162955 | COMBINATION OF AN ANTI-CD19 ANTIBODY AND A BRUTON'S TYROSINE KINASE INHIBITOR AND USES THEREOF | Incyte Corporation | NATARAJAN, MEERA | 1643 | Final Rejection | Feb 01, 2023 |
| 18092610 | PD-L1/STING CONJUGATES AND METHODS OF USE | Incyte Corporation | JARRELL, NOBLE E | 1699 | Non-Final OA | Jan 03, 2023 |
| 18085814 | SALTS AND SOLID FORMS OF AN FGFR INHIBITOR AND PROCESSES OF PREPARING THEREOF | Incyte Corporation | ELENISTE, PIERRE PAUL | 1622 | Non-Final OA | Dec 21, 2022 |
| 18081975 | Topical formulations of PI3K-delta inhibitors | Incyte Corporation | SOROUSH, LAYLA | 1622 | Non-Final OA | Dec 15, 2022 |
| 18062924 | ANTI-MUTANT CALRETICULIN (CALR) ANTIBODIES AND USES THEREOF | Incyte Corporation | MARVICH, MARIA | 1634 | Non-Final OA | Dec 07, 2022 |
| 17991482 | COMBINATION THERAPY COMPRISING AN FGFR INHIBITOR AND A KRAS INHIBITOR | Incyte Corporation | VALLE, ERNESTO | 1623 | Final Rejection | Nov 21, 2022 |
| 17674237 | PIPERIDIN-4-YL AZETIDINE DERIVATIVES AS JAK1 INHIBITORS | Incyte Holdings Corporation | MOORE, SUSANNA | 1624 | Final Rejection | Feb 17, 2022 |
| 16791561 | CYCLIN-DEPENDENT KINASE 2 BIOMARKERS AND USES THEREOF | Incyte Corporation | KATAKAM, SUDHAKAR | 1658 | Non-Final OA | Feb 14, 2020 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial